Archive for the ‘News’ Category

Come experience our therapeutic Music Therapy Movement Program

for persons with Parkinson’s disease!

This is an integrative Music Therapy movement program is specifically designed to address symptoms

of Parkinson’s disease and also other neurologic movement disorders.

This integrative program is based on research and experience designed to help:

improve balance, improve fine/gross motor coordination,

stimulate initiation of movement, reduce rigidity, help improve & coordinate walking gait

and arm swing, and enhance your social support system!

When: Every Friday from 11:15 to 12:15

Where: The Center for Creative Release on 212 Third Ave. (between Thomasville Rd. and North Monroe)


How much: FREE for first class!  $3 per class thereafter ($12 monthly package)

Instructor: Peyton Davis, MT, LNMT; mmpd3@hotmail.com

**Caretakers and family members are welcome to participate in the fun!!

This week:

We are continuing our ballroom dance series and have been having a great time!!

This will continue through the middle of August.

We are fortunate to have Kyle, a professional ballroom dance instructor teaching us beginning skills in foxtrot, waltz, box step, rumba, and tango!

Whether you love to dance or think you lack rhythm…

come surprise yourself at how your body learns to adapt and move!

No prior experience is required to participateJust come and have a great time!

1.  All movement activities are matched to the specific rhythms and carefully selected music to enhance the initiation and  coordination of movement.

2.  Activities begin with simple, isolated movements to prepare for adaptable, complex movements.

3.  All activities are adapted to meet the movement level and skills of each person!


Guest instructors are integrated in parts of the class to provide expert guidance

in stretching, formal ballroom dancing, elements of tai chi/qi gong.

Guest instructors: Kyle (Professional Ballroom Dance instructor)

Rose (Yoga Instructor, Personal Trainer)

Louise (Qi Gong Instructor)

Read Full Post »

NPF APDA Young Onset PD Conference: www.parkinson.org/yopn


Conference Fee: $30 (includes Evening Welcome Reception, Breakfast, and Lunch)

For more details click here

Read Full Post »

Kathy Wooten, a dear friend and founding member of the North Florida Parkinsons Awareness Group has passed. Kathy was an inspiration to us all and we all have fond memories of the times we spent with her. I implore you to share your memories in the comment section located at the bottom of this post.

Kathryn Blackburn Wooten went home to be with the Lord on Monday, February 23, 2009, after a long and courageous battle with Multiple System Atrophy. She passed away at home surrounded by family and friends, thanks to the loving care of Big Bend Hospice. Funeral service will be held 11 a.m. EST Thursday, February 26, in Culley’s MeadowWood Funeral Home, Riggins Road Chapel (850-877-8191), with interment to follow in Woodville Cemetery. Family will receive friends from 6 to 8 p.m. EST Wednesday in the funeral home. In lieu of flowers, memorials may be made to Big Bend Hospice, 1723 Mahan Center Blvd., Tallahassee, FL 32308, or the North Florida Parkinson’s Awareness Group, C/o Steve Sandler, President, NFPAG, 803 Chestwood Ave., Tallahassee, FL 32303. She was born in Waycross, Ga., on April 3, 1949, and moved to Tallahassee at the age of five. She was a class of 1967 graduate of Leon High School and attended Tallahassee Community College. She became a certified legal assistant and certified paralegal. She worked for the Leon County Court and the Second Judicial Court of the State of Florida, retiring after 33 years as judicial assistant. The last 17 years was spent working for the Honorable Judge John E. Crusoe. Kathy was active in Judicial Assistants Association for many years. Kathy was also an active member of the Beta Sigma Phi sorority. She was dearly loved by her sorority sisters who stood by her throughout her illness. Kathy helped in organizing the North Florida Parkinson Association as a charter member and serving as the first vice president.She remained active until the very end. She was also active in the North Florida Parkinson Choir and performed at many of the nursing homes and hospitals in the area and was an active member of the Tallahassee Woman’s Club. She is survived by her husband of 38 years, William R. Wooten Jr., and two daughters, Amy W. Hattaway (and husband Bill) and Melanie W. Dobbs (and husband Jeremy). She is also survived by two grandchildren who were the love of her life, William (Wiley) Hattaway and Grace (Gracie) Marie Dobbs; two brothers, Herbert C. Blackburn (and wife Carolyn) and Theron ( Bud) H. Blackburn (and wife Sharon); one sister, Rebecca Christine Blackburn; very close cousin, Joanne Louise Urban; her loving brothers-in-law, Robert I. Wooten (and wife Wilma) and Brian Carl Wooten (and wife Carol); and numerous nieces, nephews, great-nieces, great-nephews, cousins; and a host of friends.

Read Full Post »

Take Action

Senate Committee is Considering Defense Spending Bill!

Ask Your Senators Today to Support DoD Parkinson’s Research!
This morning, the U.S. Senate Appropriations Defense Subcommittee marked up the Defense spending bill.  The full Appropriations Committee plans to take up the Defense spending bill Wednesday.  The bill sets the funding levels for all Defense programs, including the Parkinson’s disease research program, Neurotoxin Exposure Treatment Research Program (NETRP).  With your help, we hope to make this year an historic one by securing NETRP Parkinson’s disease research funding in the Senate Defense Appropriations bill for the first time.  As you may know, PAN advocates and our congressional champions have successfully secured NETRP funding each year for ten years through the U.S. House of Representatives version of the Defense bill, but NETRP has never been funded in the Senate bill.  Please take a few minutes to e-mail your senators now to ask they support this essential Parkinson’s disease research! Although the Senate has yet to fund Parkinson’s disease research directly in the Senate Defense bill, they have agreed with their congressional colleagues in conference committee each year that this important research must be funded.  In fact, sixteen senators have already expressed their support for NETRP in April of this year.  Let’s encourage our senators to stand up for Parkinson’s disease research from day one by including Parkinson’s funding directly in the Senate Defense bill!

Read Full Post »

The following story was found at http://www.spiritindia.com/health-care-news-articles-1590.html

Regular use of the pain-relieving nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (Motrin, Advil) may delay or prevent the onset of Parkinson’s disease, according to data from roughly 147,000 U.S. men and women enrolled in the Cancer Prevention Study II Nutritional Cohort.

In 1992, subjects provided information on four types of commonly used analgesics. In 2001, they provided information on the occurrence of Parkinson’s disease. The researchers detected 413 cases of Parkinson’s disease during follow up.

“We found that individuals who regularly used ibuprofen had about a 35 percent lower risk of developing Parkinson’s disease than non-users,” Dr. Alberto Ascherio, of Harvard School of Public Health in Boston, Massachusetts, told.

Specifically, compared to those who did not use NSAIDs, users of 2 to 7 ibuprofen tablets per week had about a 28 percent reduced relative risk of developing Parkinson’s disease, while those who reported using 1 or more tablets per day had a 38 percent reduced risk of Parkinson’s.

No associations were observed between the risk of PD and the use of aspirin, other NSAIDs, or acetaminophen.

“These findings suggest that ibuprofen could contribute to the prevention of Parkinson’s disease,” Ascherio said. “Because of the progressive nature of the degenerative process, it is also possible that this drug could be beneficial for individuals with Parkinson’s, but this should be tested in randomized clinical trials.”

“It would be premature for people with Parkinson’s disease to start taking ibuprofen or other anti-inflammatory drugs,” Ascherio cautioned. “Albeit promising, these findings are insufficient to support a change in current therapeutical practice.”

Read Full Post »

Older Posts »